Last reviewed · How we verify

NCT06629870: DADRDT

Dental Anxiety During Restorative Dental Treatment

Completed NA Last updated 8 October 2024
What this trial tests

NA trial testing virtual reality in Hypnotherapy in 80 participants. Completed in 29 May 2024.

Timeline
26 February 2023
Primary endpoint
29 February 2024
29 May 2024

Quick facts

Lead sponsorAtaturk University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment80
Start date26 February 2023
Primary completion29 February 2024
Estimated completion29 May 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ataturk University

Who can join

Adults 18 to 65, any sex, with Hypnotherapy or Virtual Reality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anxiety refers to behavioural disorders associated with excessive fear and anxiety. Dental anxiety refers to excessive fear and anxiety at the thought of going to the dentist. This may cause patients to avoid dental treatments and may adversely affect oral health. This study aims to evaluate the effects of hypnotherapy, virtual reality distraction and mindfulness-based meditation practices on dental anxiety during restorative dental treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of virtual reality

Trials testing the same drug.

Other Ataturk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06629870.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing